Chitosan Oligosaccharide Alleviates Abnormal Glucose Metabolism without Inhibition of Hepatic Lipid Accumulation in a High-Fat Diet/Streptozotocin-Induced Diabetic Rat Model
Open Access
- 23 June 2021
- journal article
- research article
- Published by MDPI AG in Marine Drugs
- Vol. 19 (7) , 360
Abstract
This study investigated the effects of chitosan oligosaccharide (COS) on glucose metabolism and hepatic steatosis in a high-fat (HF) diet/streptozotocin-induced diabetic rat model. Male Wistar rats were divided into: (1) normal control (NC group), (2) HF diet (HF group), (3) streptozotocin (STZ)-induced diabetes with HF diet (DF group), and DF group supplemented with (4) 0.5% COS (D0.5F group), (5) 1% COS (D1F group), and (6) 5% COS (D5F group) for 4 weeks. COS supplementation significantly decreased the plasma glucose, BUN, creatinine, uric acid, triglyceride (TG), and total cholesterol (TC) levels, and hepatic glucose-6-phosphatase activity, and significantly increased hepatic hexokinase activity and glycogen content in diabetic rats; but the increased hepatic TG and TC levels could not be significantly decreased by COS supplementation. Supplementation of COS increased superoxide dismutase activity and decreased lipid peroxidation products in the diabetic rat livers. COS supplementation significantly increased phosphorylated AMP-activated protein kinase (AMPK) protein expression, and attenuated protein expression of hepatic phosphoenolpyruvate carboxykinase (PEPCK) and phosphorylated p38 and renal sodium-glucose cotransporter-2 (SGLT2) in diabetic rats. These results suggest that COS may possess a potential for alleviating abnormal glucose metabolism in diabetic rats through the inhibition of hepatic gluconeogenesis and lipid peroxidation and renal SGLT2 expression.Keywords
Funding Information
- College of Ocean Science and Resource, National Taiwan Ocean University (92200001)
This publication has 33 references indexed in Scilit:
- Molecular Weight Dependent Glucose Lowering Effect of Low Molecular Weight Chitosan Oligosaccharide (GO2KA1) on Postprandial Blood Glucose Level in SD Rats ModelInternational Journal of Molecular Sciences, 2013
- Chitooligosaccharides: Synthesis, characterization and applicationsPolymer Science, Series A, 2011
- SGLT2 inhibition — a novel strategy for diabetes treatmentNature Reviews Drug Discovery, 2010
- Long-term effects of chitosan oligosaccharide in streptozotocin-induced diabetic ratsIslets, 2009
- The role of protein kinase C activation in diabetic nephropathyKidney International, 2007
- Inhibition of Gluconeogenesis through Transcriptional Activation of EGR1 and DUSP4 by AMP-activated KinaseJournal of Biological Chemistry, 2006
- CCAAT/Enhancer-binding Protein α Mediates Induction of Hepatic Phosphoenolpyruvate Carboxykinase by p38 Mitogen-activated Protein KinaseJournal of Biological Chemistry, 2006
- Effect of N-benzoyl-d-phenylalanine and metformin on carbohydrate metabolic enzymes in neonatal streptozotocin diabetic ratsClinica Chimica Acta, 2005
- Integration of biochemical and physiologic effects of insulin on glucose metabolismExperimental and Clinical Endocrinology & Diabetes, 2001
- Effect of guar gum and cholestyramine on plasma lipoprotein cholesterol in rats.Nippon Eiyo Shokuryo Gakkaishi, 1990